EP-1385: Verification of dosimetric impact of attenuation plate and bolus cap in IOERT for breast cancer  by Adamczyk, S. et al.
3rd ESTRO Forum 2015                                                                                                                                         S747 
 
defined as the quotient of monitor units and dose ranged 
from 1.9 to 3.9 UM/cGy. SNC ArcCHECK is a cylindrical water-
equivalent phantom with a three-dimensional (3D) array 
diode detectors arranged in a spiral pattern with 10 mm 
sensor spacing. The SNC Patient (version 6.2) software can 
combine the standard density (SD) measurement with 
another measurement with a ±5mm Y axis shift and ±2.72 
degrees rotation. The resulting HD measurement has 0.5 mm 
spacing between points. Both, SD and HD measurements, 
were compared with the TPS calculated dose distributions. 
Three different 2D-gamma analysis were carried out: 
3%/3mm, 2%/2mm and 1%/1mm (dose difference/distance-
to-agreement criteria). 
Results: Gamma comparison using 3%/3mm showed no 
noticeable differences between HD and SD measurements. 
Setting an acceptance criterion of 95% or more passing 
points, all plans would have been accepted irrespective of 
the measurement procedure used. Further analysis reveals a 
slight difference between HD and SD results depending on 
PTV volume. It can be seen that for PTV smaller than 10 cm3 
the HD mode produces better passing rates, while this trend 
is inverted for volumes higher than 10 cm3. This passing-rate 
/ volume dependence is also seen in 2%/2mm and 1%/1mm 
gamma analysis. No trend could be seen analyzing the passing 
rate dependence with the degree of modulation. 
Conclusions: The use of diode arrays for IMRT/VMAT 
verification has been widely tested for standard plans. 
However, concern has been raised in the verification of plans 
with small PTVs, owing to their low measurement resolution. 
In the present study it is shown that, for our patient series, 
the passing rate using SD and HD measurement modes is 
almost the same. Using the 95% passing rate (3%/3mm) there 
are no differences in acceptance between both modes. 
However, HD mode needs two measurements which are more 
time-consuming than SD mode. Further investigation is 
needed to confirm the small trend observed in passing rates 
dependence on PTV volume. 
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Purpose/Objective: The aim of the study is to evaluate the 
use of Varian DynaLog files to verify VMAT plans delivery and 
modulation complexity score (MCS) of VMAT. 
Materials and Methods: Delivery accuracy of machine 
performance was quantified by multileaf collimator (MLC) 
position errors, gantry angle errors and fluence delivery 
accuracy for volumetric modulated arc therapy (VMAT). The 
relationship between machine performance and plan 
complexity were also investigated using the modulation 
complexity score (MCS). Plan and Actual MLC positions, 
gantry angles and delivered fraction of monitor units were 
extracted from Varian DynaLog files. These factors were 
taken from the record and verify system of MLC control file. 
Planned and delivered beam data were compared to 
determine leaf position errors and gantry angle errors. 
Analysis was also performed on planned and actual fluence 
maps reconstructed from those of the DynaLog files. This 
analysis was performed for all treatment fractions of 5 
prostate VMAT plans. The analysis of DynaLog files have been 
carried out by in-house programming in Visual C++. 
Results: The root mean square of leaf position and gantry 
angle errors were about 0.12 and 0.15 , respectively. The 
Gamma of planned and actual fluence maps at 3%/3 mm 
criterion was about 99.21. The gamma of the leaf position 
errors were not directly related to plan complexity as 
determined by the MCS. Therefore, the gamma of the gantry 
angle errors were directly related to plan complexity as 
determined by the MCS. 
Conclusions: This study shows Varian dynalog files for VMAT 
plan can be diagnosed delivery errors not possible with 
phantom based quality assurance. Furthermore, the MCS of 
VMAT plan can evaluate delivery accuracy for patients 
receiving of VMAT. Machine performance was found to be 
directly related to plan complexity but this is not the 
dominant determinant of delivery accuracy. 
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Purpose/Objective: Intraoperative electron beam 
radiotherapy (IOERT) is a technique which apply a single-
fraction high dose intraoperatively to the tumor bed using an 
electron beam after breast-conserving surgery. Attenuation 
plate (shielding plate) is commonly used to protect the 
normal tissues posterior to the irradiated volume. Bolus caps 
are very often introduced (45% of all cases treated) to modify 
the dose at tissue surface. The plate's and bolus’ 
performance was verified by measurements. 
Materials and Methods: Depth doses with and without the 
acrylic bolus caps were measured by radiochromic films 
(Gafchromic EBT2, ISP) using a mobile linear accelerator 
dedicated for IOERT - Mobetron 1000 (IntraOp Medical, Inc.). 
Radiochromic films were placed between the slabs of RW3 
(PTW) phantom, parallel to the central beam axis (CAX). 
After the analysis percentage Depth Dose (PDD) curves and 
isodose lines were compared between film with and without 
bolus cap mounted at the end of the applicator. The shift 
between both PDDs was calculated and surface dose has been 
compared. Secondly planar dose distribution was measured 
underneath attenuation plate using ion chamber array 
(OCTAVIUS 1000 SRS, PTW) and compared to the 
measurements for the same set-up but without plate 
inserted. In this measurement 5 cm applicator with 7 cm 
aluminum-lead disk (0.5 cm of physical thickness) were used. 
Furthermore we have estimated the dose in front of the 
shielding plate, which is affected by backscatter radiation 
(resulting in an unpredictable delivered dose to the tumour 
cells). Backscatter radiation was measured using sheets of 
radiochromic films, sandwiched between slabs of RW3 
phantom, above shielding plate and parallel to the central 
beam axis (CAX). PDD curves were then compared to the 
measurement without any attenuator. 
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Results: Based on planar dose measurements we found that 
shielding plate attenuates the beam homogenously over its 
surface. Transmission coefficients for 0.5 cm thick disk were 
0.857, 0.875, 0.872 and 0,855 for 4 MeV, 6 MeV, 9 MeV 
respectively. For 1.0 cm thick plate measured transmission 
coefficients equaled 0.667, 0.714, 0.737 and 0.739 for 4 MeV, 
6 MeV, 9 MeV respectively. 
Table 1 presents surface dose values for different electron 
energies with and without bolus cap. The shifts between 
PDDs with and without bolus cap were estimated as 0.75 cm, 
0.40 cm, 0.30 cm and 0.45 cm for 4 MeV, 6 MeV, 9 MeV 
respectively (Figure 1). 
The dose increase resulting from backscatter radiation (up to 
13.21%, 10.99% and 10.25% for 6 MeV, 9 MeV and 12 MeV 
respectively) in front of the shielding plate was observed. 
The dose increase for 4 MeV electron beam energy was 
negligible. 
 4 MeV 6 MeV 9 MeV 12 MeV 
no bolus 84,67% 89,29% 91,35% 92,36% 
with bolus 98,90% 98,19% 96,06% 93,60% 
 
 
 
Conclusions: Attenuation of shielding plates was verified and 
transmission coefficients were calculated. Considerable dose 
increase in front of the shielding plate was observed for 
electron beam energies higher than 4 MeV. We observed a 
significant increase in surface dose, especially for lower 
electron beam energies. 
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Purpose/Objective: The aim of this work is to evaluate the 
feasibility of ArcCHECK (AC) and 3DVH v3.1.0 software 
(SunNuclear Corporation) for QA verification of VMAT patient 
plans with very small fields, FFF beams, high dose rates and 
high absorbed doses. We use other traditional QA systems 
such as Gafchromic EBT3 film, and dose point with a PinPoint 
(PTW) ionization chamber for comparison as well. 
Materials and Methods: Four RapidArc plans with very small 
targets in different body locations and different beam 
energies were selected: usual head SRS (4.9 cm3) with X6FF 
beam energy and dose rate up to 600 MU/min, a head SRS 
(4.9 cm3) with X6FFF and up to 1400 MU/min, a lung SBRT 
(18.1 cm3) with X6FFF and up to 1400 MU/min in order to 
deal with heterogeneities and an abdominal SBRT (53.4 cm3) 
with X10FFF beam energy and dose rate up to 2400 MU/min 
(maximum dose rate). The 3D dose distributions were 
calculated by Eclipse with AAA v10.28 algorithm. 
Measurements were performed in a Varian TrueBeam Linac 
2.0. All treatment plans were verified by AC system. 
Measurements with the diode array were compared with TPS 
calculations assessed in AC phantom virtual image set with an 
homogeneous mass density of 1.19 g/cm3. 3D gamma analysis 
was used for the comparison. 
For EBT3 film and PinPoint measurements, a cylindrical solid 
water phantom was used. 2D gamma analysis was used to 
compare film's planar dose distribution with the TPS in the 
convenient plane of the cylindrical phantom. Seven points 
were taken into account for chamber measurements in order 
to assess setup uncertainties, considering a potential setup 
error of 1 mm in any direction. 
In the three different systems, measurement to calculation 
comparisons were evaluated under usual passing rate gamma 
analysis global and local criteria: 3%/3 mm, 2%/2 mm and 
1%/1 mm, dose difference and DTA, with a threshold pf a 10% 
maximum dose. 
3DVH software was also evaluated assessing AC dose 
measurements inside the patient CT image set and comparing 
with the TPS calculations. 
Results: Results for γ-analysis and point dose are shown in 
table 1. 
 
 
Comparing 3DVH results with histograms calculated by TPS, 
differences around 4-8% on average were found in ICRU 83 
parameters for PTV, GTV, ITV and OARs. 
Conclusions: Global and local gamma passing rate analysis 
were done for AC and EBT3 film under γ(3%/3 mm), γ(2%/2 
mm) and γ(1%/1 mm) criteria. Point dose measurements with 
PinPoint chamber were also done. Results with film and 
chamber, used as a gold standard, warrant that AC 
measurements were in good agreement with TPS 
calculations. 3DVH has proven to be a good tool to assess 
dose distribution inside the patient. Thus AC with 3DVH is 
suitable for clinical use under FFF beams, very small fields, 
high dose rates and high absorbed doses conditions as long as 
4% to 8% differences are considered to be acceptable.  
 
 
 
 
 
 
 
